Key result
Cancer is linked to higher postoperative VTE risk, though confounding risk factors may contribute.
Why the study?
The association between cancer and increased risk of venous thromboembolism remains uncertain, especially in non-surgical patients and across different cancer types.
Do patients with cancer have an increased risk of venous thromboembolism?
Do patients with cancer have an increased risk of venous thromboembolism?
This review highlights the need for further studies to clarify the clinical and pathogenetic association between various types of cancer and venous thromboembolism.
Supports heightened postoperative VTE vigilance in cancer; leaves open whether malignancy itself or comorbidities drive the association.
The literature was reviewed in an attempt to determine whether patients with cancer have an increased risk of venous thromboembolism, i.e. deep vein thrombosis and pulmonary embolism. From case reports it was apparent that various thromboembolic or thrombophlebitic manifestations may be found in a small number of patients, although it is possible that not all cases belong to the same clinical or pathogenetic entity. In clinical series it was found that the risk of postoperative venous thromboembolism was increased in cancer patients, but the possibility that this was due to associated risk factors, rather than to the mere presence of a tumour, could not be excluded. Little is known about patients not undergoing surgery. Retrospective postmortem studies have found more thrombi in patients with malignancy, but a prospective study failed to demonstrate an association between malignancy and pulmonary embolism. It is possible that different types of cancer show various degrees of association with venous thromboembolism. We conclude that further studies should be performed to provide a firm clinical and pathoanatomical basis for investigations into the pathogenesis of venous thromboembolism.
No takes yet. Share an insight, caveat, or question.
Rahr et al. (1992) conducted a review in Cancer and venous thromboembolism. Cancer was evaluated on Venous thromboembolism (deep vein thrombosis and pulmonary embolism). A literature review found an increased risk of postoperative venous thromboembolism in cancer patients, but could not exclude the role of associated risk factors rather than the tumor itself.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: